| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Scientific Officer
1 company
Neal Flomenberg is See Remarks at TVGN. Neal Flomenberg's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $455K at current prices.
Our model assigns Neal Flomenberg a below-average insider score of 48/100, based on 11 past trades. Over a 12-month horizon, 37.5% of those trades were profitable, with an average 12-month return of -34.8%.
The TVGN filings lean toward selling, a net 1,738,266 shares.
Neal Flomenberg has 7 Form 4 filings on record from February 2024 to March 2026, all as Tevogen Bio (TVGN), 2024–2026.
The 13 reported transactions were 11 open-market sales and 2 stock awards.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $2.5M.
The largest open-market sale was 1,078,600 shares of TVGN at an average $1.62 on October 17, 2024, about $1.7M. Twelve months later TVGN was down 49%.
None of the 5 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | TVGN Tevogen Bio Holdings Inc. | See Remarks | Sell | 972 | $6.83 | $6,635.17 | -1.2% | +116.9% | - | |
| Mar 12, 2025 | TVGN Tevogen Bio Holdings Inc. | See Remarks | Sell | 232,968 | $1.09 | $253,935.12 | -6.1% | +11.7% | +474.8% | |
| Mar 11, 2025 | TVGN Tevogen Bio Holdings Inc. | See Remarks | Sell | 211,909 | $1.09 | $231,734.38 | -5.2% | +2.8% | +599.1% | |
| Mar 6, 2025 | TVGN Tevogen Bio Holdings Inc. | See Remarks | Sell | 213,817 | $1.17 | $250,006.21 | -5.0% | +18.2% | +540.9% | |
| Oct 17, 2024 | TVGN Tevogen Bio Holdings Inc. | See Remarks | Sell | 1,078,600 | $1.62 | $1,747,332.00 | -20.2% | -9.4% | -49.2% |